Please login to the form below
Henrik Stenqvist joins Recipharm
Was previously CFO for Meda Group
Recipharm appoints Henrik Stenqvist as its new executive VP and chief financial officer, bringing 24 years of finance and management experience.
He said: “I’m looking forward to contributing to the continued success of Recipharm in my new capacity as chief financial officer of this leading company.”
Prior to joining Recipharm, Stenqvist served as CFO for Meda Group and has held other finance positions in the pharmaceutical industry.
Thomas Eldered, CEO of Recipharm, said: “I am very pleased to welcome Henrik, his extensive experience and perspectives in finance, business and strategic development in the pharmaceutical industry make him a great fit for Recipharm as we continue on our strong growth path.”
Stenqvist will be based at the company’s headquarters in Stockholm, Sweden where he will focus on financial planning and reporting.
Featured jobs
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director, Medical Education
-
Salary TBC
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Account Manager
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Director
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
- Client Services Director - Digital MedComms
-
£60000 - £80000 per annum, Benefits: Pension, healthcare, dedicated training budget, regul
-
Publications director
-
Competitive salary and bonus scheme
-
Account Manager (PR)
-
Great Benefits
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
Subscribe to our email news alerts
- J&J gets US backing for vaccine against coronavirus, christened Covid-19
- Genital herpes vaccine candidate heads for human studies
- It started with a miss
- Merck chases Roche with triple-negative breast cancer data for Keytruda
- CRISPR gene-editing in cancer patients is safe, according to new study
- A market-adapted agile approach to launch excellence
- AZ revenues rise, but it says coronavirus could hit 2020
- Seattle Genetics wins FDA priority review for oral HER2 drug
- Eisai agrees to pull obesity drug Belviq after safety alert
- FDA begins speedy review of BMS’ CAR-T liso-cel
- It’s Teenage Kicks for Lucid Group
- 20 for 2020 – Five pharma companies to watch
No results were found
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- 20 for 2020 – Five pharma companies to watch
- As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
- The growing clinical importance of patient-reported outcomes (PROs)
- Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
- The roaring ‘20s and Generation Z
- How a new generation will shape pharma comms this decade...
Quick links
Infographics
